Increased CD56+ natural killer cells and related cytokines in major depression

A Seidel1, V Arolt, M Hunstiger

  • 1Institute of Immunology and Transfusion Medicine, University of Lübeck School of Medicine, Germany.

Insights

Major depression patients exhibit elevated CD56+ natural killer (NK) cell counts and enhanced lymphokine production. This correlation was significant during acute illness but diminished with clinical improvement.

Area of Science:

  • Immunology
  • Neuroscience
  • Psychiatry

Background:

  • Major depression is a complex disorder with potential immune system dysregulation.
  • Natural killer (NK) cells and their associated lymphokines play roles in immune function and mood disorders.

Purpose of the Study:

  • To investigate CD56+ NK cell counts and lymphokine production (interleukin-2, interferon-gamma) in major depression patients.
  • To explore the relationship between NK cell activity and clinical status in depression.

Main Methods:

  • Flow cytometry was used to quantify CD56+ NK cell counts in 27 inpatients over 6 weeks.
  • Whole blood assays measured interleukin-2 and interferon-gamma responses to phytohemagglutinin (PHA) stimulation.

Main Results:

  • Patients with major depression showed significantly higher CD56+ NK cell counts compared to controls.
  • A greater lymphokine response to PHA was observed in patients during their acute clinical stage.
  • A significant correlation between lymphokine secretion and CD56+ NK cell counts was found in the acute phase of depression.

Conclusions:

  • Elevated CD56+ NK cell counts and enhanced lymphokine production are associated with the acute phase of major depression.
  • The correlation between NK cell activity and lymphokine secretion suggests a role for these immune components in depression pathophysiology.
  • Immune markers may normalize with clinical improvement, indicating a dynamic relationship between depression and immune function.